New research is shedding light on how fat cells may play a direct role in fueling the growth of certain aggressive breast cancers. The study, published in Nature Communications, explores a biological mechanism that could help explain why being overweight or obese is linked to increased breast cancer risk, particularly for triple-negative breast cancer. This form of cancer, which accounts for about 15% of all breast cancer cases, is known for its aggressive nature and limited treatment options. The findings may open the door to potential therapies that target how tumors interact with nearby fat cells.

The researchers, led by Jeremy Williams, a postdoctoral scholar at the University of California, San Francisco, discovered that some breast tumor cells can tap into the energy stored in neighboring fat cells. They do this by extending a straw-like structure, known as a gap junction, into the fat cells to extract lipids—fatty compounds like cholesterol that the body uses for energy storage. This process allows the tumor cells to essentially "feed" off the fat cells, promoting their own growth and survival.

Williams and his team conducted a series of experiments using both human tissue samples and mouse models. In human tissue, they observed that fat cells located closer to tumor cells were more depleted of lipids than those farther away. This suggested a direct interaction where the tumor cells were actively drawing nutrients from nearby fat. When the researchers blocked the ability of the cancer cells to form these gap junctions, tumor growth stopped. In mouse models, genetically altering the tumor cells to reduce their capacity to form these structures also led to a significant decrease in tumor formation and progression.

“Aggressive cancer cells can co-opt different nutrient sources to help them grow, including by stimulating fat cells in the breast to release their lipids,” Williams explained. “In the future, new treatments might starve the tumor cells by preventing their access to lipids from neighboring cells.”

This discovery is especially relevant for triple-negative breast cancer, a subtype that disproportionately affects Black women and women under 40. It also tends to recur more frequently and lacks the hormone receptors that other breast cancers use for targeted treatments, making it more difficult to treat.

Dr. Julia McGuinness, a breast cancer specialist and assistant professor of medicine at Columbia University Vagelos College of Physicians and Surgeons, described the research as the first evidence of a mechanism linking fat cells and cancer growth. “It’s suggesting one pathway to treat aggressive cancers for which we don’t have any good therapies,” she said. McGuinness also noted that obesity has already been established as a risk factor for all types of breast cancer, and that lifestyle changes aimed at achieving a healthy weight might offer some protection. “Slimming down could be protective,” she added.

The implications of this study go beyond triple-negative breast cancer. According to the researchers, any cancer that utilizes fat as an energy source could potentially be affected by this mechanism. That broadens the scope of the findings and suggests a new area of focus in cancer treatment research: how tumors exploit the body’s own fat stores for sustenance.

Justin Balko, the Ingram professor of cancer research at Vanderbilt University Medical Center, emphasized the significance of the discovery while also noting some limitations. “They found a new way cancer grows and feeds itself,” he said. “If some of the same effects are observed in humans, it might be fodder for differences in the way we treat patients.” However, Balko cautioned that more research is needed to determine whether this is a major mechanism in human breast cancer growth. “But it makes a lot of sense,” he added.

One particularly promising aspect of the study is that several medications already being studied in early-phase clinical trials for other conditions are known to inhibit gap junction formation. This raises the possibility that existing drugs could be repurposed to block the lipid-harvesting behavior of cancer cells. If successful, such treatments could offer a less invasive and more targeted approach to managing aggressive cancers.

The study also underscores the importance of understanding the metabolic needs of cancer cells. By identifying how tumors source their energy, researchers can develop strategies to cut off their supply lines. In this case, the focus is on lipids, which play a critical role in energy storage and cellular function. Blocking access to these resources could effectively starve the tumors, halting their growth without harming surrounding healthy tissue.

I found this detail striking: when the researchers knocked out a single gene responsible for forming the gap junctions, tumor development was significantly impaired. This suggests that even small genetic interventions might have powerful effects, offering hope for more targeted and less toxic treatment options in the future.

While the findings are still in the early stages and primarily based on lab models, they offer a compelling new direction for cancer research. The idea that fat cells could be more than passive bystanders in cancer development—and may in fact be active contributors—adds a new layer of complexity to our understanding of the disease. It also reinforces the importance of maintaining a healthy weight as part of an overall cancer prevention strategy.

As scientists continue to explore these mechanisms, the hope is that new therapies can be developed to intercept the metabolic pathways tumors use to thrive. For patients facing aggressive cancers like triple-negative breast cancer, such advances could offer new avenues for treatment where few currently exist.

Read more at nbcnews.com